Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions

Diabetes, Metabolic Syndrome and Obesity

Volumn 4, Issue , 2011, Pages 1-4

  Rodríguez, Angel ^a   Delgado Cohen, Helena ^a   Reviriego, Jesús ^a   Serrano Ríos, Manuel ^b  

^a ELI LILLY AND COMPANY   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Epidemiologic studies; Metabolic syndrome; Risk factors; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

AGED; ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; EDUCATION PROGRAM; ENDOCRINE DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INSULIN TREATMENT; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 79953110231     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSOTT.S13457     Document Type: Article

References (9)

1. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL; SMART Study Group. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004;25(4):342-348.
2. Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998;97(10):996-1001.
3. Nesto RW. Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am J Med. 2004;116 Suppl 5A:11S-22S.
4. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In: National Diabetes Data Group-National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes in America, 2nd ed. NIH publication No. 95-1468. Bethesda, MD: National Institutes of Health; 1995:233-258.
5. Betteridge DJ. The interplay of cardiovascular risk factors in the metabolic syndrome and type 2 diabetes. Eur Heart J Suppl. 2004;6 Suppl G: G3-G7.
6. Hillier TA, Fosse S, Balkau B, Simon D, Eschwège E, Fagot-Campagna A. Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes- the ENTRED study. J Cardiometab Syndr. 2006;1(15):318-325.
7. Rodríguez A, Polavieja P, Reviriego J, Serrano M. Prevalence of the metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain. Endocrinol Nutr. 2010;57(2):60-70.
8. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709-2716.
9. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683-689.